Wolverine Asset Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Wolverine Asset Management's NAMSW Position: Q3 2026 in Review

Wolverine Asset Management increased its NewAmsterdam Pharma Warrant (NAMSW) stake by 17% in Q3 2026, buying an estimated $41.2K and bringing the position to 17,464 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Wolverine Asset Management first reported a position in NAMSW in Q4 2022 and has held it in 8 quarters since. The position peaked at $319K in Q2 2026. 1 fund tracked by Wall St. Rank holds NAMSW as of Q3 2026.

• Wolverine Asset Management held 17,464 shares of NewAmsterdam Pharma Warrant worth $221K as of Q3 2026.
• Wolverine Asset Management bought 2,539 NewAmsterdam Pharma Warrant shares in Q3 2026, an estimated $41.2K.
• NewAmsterdam Pharma Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #1143 holding.
• Wolverine Asset Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and has held it in 8 quarters since.
• Wolverine Asset Management's NewAmsterdam Pharma Warrant position peaked at $319K in Q2 2026.
• 1 fund tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.